Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Western blot analysis for p16. HeLa cell lysate (Component No. 51-16516N) was probed with the Mouse Anti-Human p16 antibody (clone G175-405, Component No. 51-1325GR) at concentrations of 0.25 (lane 1), 0.125 (lane 2), and 0.06 µg/ml (lane 3). p16 is identified as a band of 16 kDa.
Western blot analysis for p16. HeLa cell lysate (Component No. 51-16516N) was probed with the Mouse Anti-Human p16 antibody (clone G175-405, Component No. 51-1325GR) at concentrations of 0.25 (lane 1), 0.125 (lane 2), and 0.06 µg/ml (lane 3). p16 is identified as a band of 16 kDa.
Western blot analysis for p16. HeLa cell lysate (Component No. 51-16516N) was probed with the Mouse Anti-Human p16 antibody (clone G175-405, Component No. 51-1325GR) at concentrations of 0.25 (lane 1), 0.125 (lane 2), and 0.06 µg/ml (lane 3). p16 is identified as a band of 16 kDa.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Cyclins and cyclin-dependent kinases (cdks) form active complexes that regulate key events during the progression of the cell cycle and are evolutionarily highly conserved. The p16 protein has been identified as a specific inhibitor of cdk4 because it blocks cdk4 substrate phosphorylation. p16 inhibits cdk4 dependent phosphorylation of the tumor suppressor retinoblastoma protein (Rb) and Rb related proteins, p107 and p130. The biochemical properties of p16 suggest that it may be a tumor suppressor gene product. Recently a gene cloned from the short arm of human chromosome 9, Multiple Tumor Suppressor 1 (MTS1) has been identified as the gene for p16. The gene, now also known as the CDKN2 gene, has been found to be mutated in a very high percentage of tumors, including 75% of melanoma cell lines.
Store both the Purified Mouse Anti-Human p16 antibody (component 51-1325GR) and the HeLa control lysate (component 51-16516N) undiluted at -20°C.
Western blot: For additional protocols on Western blotting, please refer to "Cell Biology (WB, IP, IHC, IF)" at our website: http://www.bdbiosciences.com/us/s/resources
Endogenous p16 has been detected in several cell lines including Saos-2 human osteosarcoma (ATCC HTB-85), WI-38 human lung fibroblast (ATCC CCL-75), HeLa cervical carcinoma (ATCC CCL-2) and 293 adenovirus immortalized human kidney (ATCC CRL-1573) cells. U-2 OS human osteosarcoma (ATCC HTB-96) and MCF7 human breast carcinoma (ATCC HTB-22) have been reported to have undetectable levels of p16 and are suggested as negative controls.
The differential tissue expression of p16 remains to be characterized by immunohistochemistry. Yeager et al. has reported p16 to be both nuclear and cytoplasmic in melanoma.
| Description | Quantity/Size | Part Number | Clone | Isotype |
|---|---|---|---|---|
| Purified Mouse Anti-Human p16 | 50 µg (1 ea) | 51-1325GR | G175-405 | IgG1, |
| HeLa Control Lysate | 50 µg (1 ea) | 51-16516N | N/A | N/A |
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Refer to manufacturer's instructions for use and related User Manuals and Technical Data Sheets before using this product as described.
Comparisons, where applicable, are made against older BD technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.